This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chehadeh, W.
Right arrow Articles by Hober, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chehadeh, W.
Right arrow Articles by Hober, D.

 Previous Article  |  Next Article 

Journal of Virology, November 2005, p. 13882-13891, Vol. 79, No. 22
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.22.13882-13891.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Viral Protein VP4 Is a Target of Human Antibodies Enhancing Coxsackievirus B4- and B3-Induced Synthesis of Alpha Interferon

Wassim Chehadeh,1,{dagger} Pierre-Emmanuel Lobert,1 Pierre Sauter,1 Anne Goffard,1 Bernadette Lucas,1 Jacques Weill,2 Marie-Christine Vantyghem,3 Gunnar Alm,4 Pascal Pigny,5 and Didier Hober1*

Service de Virologie/UPRES EA3610, Faculté de Médecine-Université Lille 2, Bâtiment Paul Boulanger, CHRU Lille, 59037 Lille,1 Unité d'Endocrinologie Pédiatrique, Clinique de Pédiatrie, CHRU Lille,2 Service d'Endocrinologie et Maladies Métaboliques, Clinique Marc Linquette, CHRU Lille,3 INSERM U560, Place de Verdun, Lille, France,5 Department of Molecular Biosciences, Swedish University of Agriculture Sciences Biomedical Center, Uppsala, Sweden4

Received 25 March 2005/ Accepted 3 August 2005

Coxsackievirus B4 (CVB4)-induced production of alpha interferon (IFN-{alpha}) by peripheral blood mononuclear cells (PBMC) is enhanced in vitro by nonneutralizing anti-CVB4 antibodies from healthy subjects and, to a higher extent, from patients with insulin-dependent diabetes mellitus. In this study, we focused on identification of the viral target of these antibodies in CVB systems. High levels of IFN-{alpha} were obtained in supernatants of PBMC incubated with CVB4E2 or CVB3 and plasma from healthy subjects and, to a higher extent, from patients. The VP4 capsid proteins dissociated by heating at 56°C from CVB4E2 (VP4CVB4) and CVB3 (VP4CVB3) but not H antigen preincubated with plasma from healthy subjects or patients inhibited the plasma-dependent enhancement of CVB4E2- and CVB3-induced IFN-{alpha} synthesis. There was no cross-reaction between VP4CVB4 and VP4CVB3 in the inhibiting effect. IFN-{alpha} levels in culture supernatants showed dose-dependent correlation with anti-VP4 antibodies eluted from plasma specimens using VP4-coated plates. There were higher index values for anti-VP4 antibodies detected by enzyme-linked immunosorbent assay (ELISA) and higher proportions of positive detection in 40 patients than in 40 healthy subjects (80% versus 15% for anti-VP4CVB4). There was no relationship between the levels of anti-CVB neutralizing antibodies and the detection of anti-VP4 antibodies by ELISA. The CVB plasma-induced IFN-{alpha} levels obtained in PBMC cultures in the anti-VP4 antibody-positive groups were significantly higher than those obtained in the anti-VP4 antibody-negative groups regardless of the titers of anti-CVB neutralizing antibodies. These results show that VP4 is the target of antibodies involved in the plasma-dependent enhancement of CVB4E2- and CVB3-induced IFN-{alpha} synthesis by PBMC.


* Corresponding author. Mailing address: Service de Virologie/ UPRES EA3610, Faculté de Médecine, Université Lille 2, Bâtiment Paul Boulanger, CHRU Lille, 59037 Lille, France. Phone: 33 3 20 44 69 30. Fax: 33 3 20 44 52 81. E-mail: dhober{at}chru-lille.fr.

{dagger} Present address: Department of Microbiology, Faculty of Medicine, Health Science Center, Kuwait University, P.O. Box 24923, 13110 Kuwait City, Kuwait.


Journal of Virology, November 2005, p. 13882-13891, Vol. 79, No. 22
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.22.13882-13891.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Carragher, D. M., Kaminski, D. A., Moquin, A., Hartson, L., Randall, T. D. (2008). A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus. J. Immunol. 181: 4168-4176 [Abstract] [Full Text]